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CART-CONTAINING NEURONS IN THE NUCLEUS ACCUMBENS
PROJECT TO THE VENTRAL PALLIDUM IN THE RAT AND MAY
INHIBIT COCAINE-INDUCED LOCOMOTION
G. W. Huberta,*, D. F. Manvicha, and M. J. Kuhara
aDivision of Neuroscience, Yerkes National Primate Research Center of Emory University, 954
Gatewood Rd NE, Atlanta, Georgia, 30322, USA
Abstract
We have previously demonstrated that cocaine- and amphetamine-regulated transcript (CART)
peptide colocalizes with GABA, dynorphin, D1 receptors, and substance P in some neurons in the
nucleus accumbens. One of the main nuclei that receive accumbal efferents is the ventral
pallidum, and both dynorphin and substance P have been shown to be present in the cell bodies
and terminals of this projection. Thus, we investigated whether CART peptide is also present in
the ventral pallidum in terminals that originate in the accumbens. The anterograde tracer PHA-L
colocalized with CART in neuronal processes in the ventral pallidum when injected into the
nucleus accumbens. Also, CART colocalized with the retrograde tracer r-BDA in accumbens cell
bodies after the tracer was injected into the ventral pallidum. Using electron microscopic
immunocytochemistry, we examined CART terminals in the ventral pallidum and found that
CART-immunoreactive terminals formed symmetric synapses consistent with inhibitory
GABAergic synapses. These synapses closely resemble GABAergic synapses in the substantia
nigra pars reticulata, another nucleus that receives some CART–containing accumbal efferents.
Lastly, we found that intra-pallidal injection of CART 55–102 inhibited cocaine-induced
locomotion, indicating that CART peptide in the ventral pallidum can have functional effects.
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A fragment of a CART peptide was first discovered in an extract from ovine hypothalamus .
It was later found that an mRNA was increased after acute administration of cocaine or
amphetamine, and the mRNA sequence included the portion coding for the peptide
discovered by Speiss, et al. (Spiess et al., 1981, Douglass et al., 1995). The mRNA was
named CART for “Cocaine and Amphetamine Regulated Transcript” (Douglass et al.,
1995). The increase in the level of the transcript in response to psychostimulant drug
administration suggested that the product of this gene was a substance related to the action
of psychostimulant drugs, and the increased level further suggested an increased need for or
release of the gene product. Recently, it was shown that cocaine administration increased the
proportion of CART neurons in the nucleus accumbens (NAcc) that demonstrated Fos
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immunoreactivity (Hubert and Kuhar, 2008), which was reversible, and saline did not cause
this increase. These findings strengthen the idea that CART-containing neurons are activated
by injection of cocaine. Also, it was recently shown that intra-accumbal injections of CART
55–102 decrease cocaine self-administration (Jaworski et al., 2008). CART peptides have
also been shown to be involved in a variety of other physiologic functions, including food
intake, stress, endocrine control and other processes (Hurd et al., 1999, Larsen et al., 2002,
Hunter and Kuhar, 2003, Dominguez et al., 2004, Kuhar et al., 2005, Murphy, 2005, Rogge
et al., 2008)
In the NAcc, CART peptides are colocalized with GABA, substance P and dynorphin in
some of the medium spiny neurons (Dallvechia-Adams et al., 2002, Hubert and Kuhar,
2005, 2006). In addition, CART peptides are found in the same neurons that contain
dopamine D1 receptors (Hubert and Kuhar, 2006). Taken together, these data demonstrate
that CART neurons are a subset of NAcc medium spiny neurons that are part of the direct
pathway of information that flows through the basal ganglia (Wichmann and DeLong,
1998). Previous work on the anatomy of CART neurons has shown a CART-containing
projection from the NAcc core to the substantia nigra pars reticulata (SNr) of the rat
(Dallvechia-Adams et al., 2002).
The ventral pallidum (VP) is another major recipient of NAcc efferents, and the possibility
of this nucleus receiving a projection of CART-containing neurons from the NAcc has not
previously been investigated. The VP is a nucleus involved in processes associated with
both the basal ganglia and extended amygdala systems (Kretschmer, 2000, Heimer, 2003,
Smith et al., 2009). The connectivity of VP afferents and efferents reflects this classification,
sending and receiving projections from the NAcc core and shell, amygdala,
pedunculopontine tegmentum, lateral hypothalamus and other regions (Zahm, 1989,
Groenewegen et al., 1993, Churchill and Kalivas, 1994). It has been shown that injections of
opiates into the VP modulate the hedonic value or “liking” of natural rewards such as
sucrose, as well as elicit locomotor activity (Churchill and Kalivas, 1999, Smith and
Berridge, 2005, 2007). The VP is requisite for reward and motivational processes and
encodes hedonic events (Smith et al., 2009). Since psychomotor stimulants affect the reward
and reinforcement circuits in mammals, as well as locomotor systems, we examined whether
CART neurons in the NAcc project to the VP and have a role in psychomotor stimulant-
induced locomotion.
In this study, in order to determine if CART-containing neurons project to the VP, we
performed anterograde and retrograde tracing studies of CART-containing neurons from the
NAcc to the VP. It has been well documented that the NAcc has a significant projection to
the VP, but it is not known whether the subset of NAcc neurons that contain CART
contribute to this projection. We also examined the morphology of CART-containing
terminals at their synapses in the VP at the electron microscopic level. In addition, studies
were conducted to assess the functional effect of injecting CART peptide into the VP on
saline- and cocaine-stimulated locomotor activity.
Experimental Procedures
Animals and Tissue Preparation
Sixteen adult, male, Sprague-Dawley rats (Charles River, Wilmington MA) were used in the
anatomical experiments. For perfusion, all animals were given an injection of pentobarbital
(10mg/kg, i.p.) Within minutes of loss of tail pinch reflex, all rats were transcardially
perfused with at least 100 ml of cold, oxygenated Ringer’s solution. This was followed by
perfusion with 500 ml of fixative containing 4.0% paraformaldehyde and 0.1%
glutaraldehyde, dissolved in phosphate buffer (PB, 0.1M, pH 7.4). Brains were removed
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from the skull and stored in 30% sucrose solution in PB (for immunofluorescence or light
microscopy) or PBS (for electron microscopy) at 4°C until brains were saturated. The brains
were then cut into 60 µm-thick coronal sections on a freezing microtome. Sections were put
in a 1.0% sodium borohydride solution dissolved in phosphate buffered saline (PBS) for 20
min and rinsed with PBS before being processed for immunocytochemistry. The anesthesia
and euthanasia procedures were carried out according to the National Institutes of Health
Guidelines, and a protocol describing these experiments has been approved by the
Institutional Animal Care and Use Committee of Emory University.
Tract tracing experiments
For anterograde tracing experiments, all rats received either a unilateral or bilateral
iontophoretic injection of the anterograde tracer PHA-L in the NAcc (AP +1.6mm; LM +/−
0.8mm; DV −7.3mm (Paxinos and Watson, 1986). After being anesthetized with isoflurane,
the rats were fixed in a stereotaxic frame (Knopf). A glass micropipette (20–35 m tip
diameter), containing PHA-L (2.5% in 0.1 M, pH 8.0, phosphate buffer; (Vector,
Burlingame, CA) was placed in the NAcc shell, and iontophoretic delivery of tracer was
performed with a 7-nA positive current for 20 minutes via a 7-seconds-on/7-seconds-off
cycle. After the appropriate survival period (10–12 days), the rats were perfusion fixed as
described above. The brains were serially cut (60-m-thick sections) and reacted with sodium
borohydride. To reveal the injection site, sections of each rat brain was processed for PHA-L
using light microscopy as described above. To examine the colocalization of PHA-L and
CART, the double immunofluorescence method was used.
The retrograde experiments involved the stereotaxic, iontophoretic injection of rhodamine-
conjugated dextran amines (R-DA) using the same parameters as the anterograde tracing
experiments. The injections were made into the VP at the coordinates AP −.26mm; LM +/−
2.5mm; DV −8.0mm (Paxinos and Watson, 1986). We were not able to visualize at the
injection sites using an antibody for R-DA using LM procedures, presumably because of
interference from the attached rhodamine moiety. Colocalization of r-BDA and CART in the
NAcc was also studied using fluorescence immunochemistry.
Antisera
Commercially available antibodies for PHA-L raised in mouse (Vector, Burlingame, CA),
and custom antibodies for CART peptide raised in rabbit (Koylu et al., 1997) were used. For
Immunofluorescence, secondary antibodies raised in donkey coupled to either CY3 or FITC
(Jackson Laboratories, West Grove, PA) were used to visualize the localization of the
proteins of interest.
Immunofluorescent Localization of CART Peptides and PHA-L
The tissue sections were preincubated in a solution containing 5% normal donkey serum
(NDS), 1.0% bovine serum albumin (BSA), and 0.3% Triton X-100 in PBS for one hour.
They were then incubated overnight with primary antisera for CART and/or c-Fos diluted to
0.5–1.0 µg/ml in a solution containing 1.0% NDS, 1.0% BSA, 0.3% Triton X-100 in PBS.
Next, the sections were rinsed in PBS and transferred for one hour to a secondary antibody
solution containing FITC- (for CART) and CY3-(for c-Fos) conjugated secondary
antibodies diluted 1:100 in the primary antibody diluent solution. The tissue sections were
then washed in PBS and incubated in cupric sulfate solution for 30 minutes to enhance
visualization. Sections were then mounted on gelatin-coated slides and dried, and a coverslip
was applied with Vectashield mounting agent (Vector, Burlingame, CA) and sealed using
clear fingernail polish. Specimens were observed throughout the rostrocaudal length (2.7 to
0.7 mm according to Paxinos and Watson (Paxinos and Watson, 1986) of the nucleus
accumbens using a Zeiss LSM 410 confocal microscope. Accumbal neurons that displayed
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CART-IR were scanned on the confocal microscope for the presence of double labeling.
Due to the limitations of darkfield, oil-immersion confocal microscopy, where it is difficult
to precisely define the border between core and shell, no distinction is made between the
accumbens core and shell.
The antisera for CART peptide is directed against the C-terminal portion and will therefore
recognize proCART and its various processed forms. While this manuscript refers to
“CART peptide”, what is being localized are several CART peptides (Koylu et al., 1998),
including the active peptides, CART 55–102 and CART 62–102.
Light Microscope Procedures
The sections were preincubated in a solution containing 10% normal goat serum (NGS),
1.0% bovine serum albumin (BSA), and 0.3% Triton X-100 in PBS for one hour. They were
then incubated overnight with either primary antisera diluted at 0.5–1.0 µg/ml in a solution
containing 1.0% NGS, 1.0% BSA and 0.3% Triton X-100 in PBS. Next, the sections were
rinsed in PBS and transferred for one hour to a secondary antibody solution containing
biotinylated goat-anti-rabbit IgGs (Vector, Burlingame, CA) diluted 1:200 in the primary
antibody diluent solution. After rinsing, sections were put in a solution containing 1:100
avidin-biotin-peroxidase complex (ABC, Vector, Burlingame, California). The tissue was
then washed in PBS and 0.05M TRIS buffer before being transferred to a solution
containing 0.01M imidazole, 0.0005% hydrogen peroxide, and 0.025% 3,3’-
diaminobenzidine tetrahydrochloride (DAB, Sigma, St. Louis, MO) in TRIS for 7–10
minutes. Sections were then mounted on gelatin-coated slides and dried, and a coverslip was
applied with Permount.
Electron Microscope Procedures
After vibratome cutting, sections were transferred to a cryoprotectant solution (PB, 0.05M,
pH 7.4 containing 25% sucrose and 10% glycerol) for 20 min. They were then frozen in a
−80°C freezer for 20 min, returned to a decreasing gradient of cryoprotectant solutions and
rinsed in PBS. Sections then underwent immunocytochemical procedures for the
immunoperoxidase localization of CART in a manner identical to that for the light
microscope, except that the incubation in the primary antisera was carried out at 4 C for 48
hours and that Triton-X-100 was omitted from all incubation solutions.
The sections were then transferred to PB (0.1M, pH 7.4) for 10 minutes and exposed to 1%
osmium tetroxide for 20 minutes. They were then rinsed with PB and dehydrated in an
increasing gradient of ethanol. Uranyl acetate (1%) was added to the 70% alcohol to
increase contrast at the electron microscope. The sections were then treated with propylene
oxide before being embedded in epoxy resin (Durcupan, ACM, Fluka, Buchs, Switzerland)
for 12 hr, mounted on microscope slides and placed in a 60°C oven for 48 hrs.
Pieces of VP tissue were taken out from the slides and glued on the top of resin blocks with
cyanoacrylate glue. They were cut into 60 nm ultrathin sections with an ultramicrotome
(Ultracut T2, Leica, Nussloch, Germany) and serially collected on single-slot Pioloform-
coated copper grids. The sections were stained with lead citrate for 5 min (Reynolds, 1963)
and examined with a Zeiss EM-10C electron microscope (Thornwood, NY).
Locomotor Activity Studies
Rats (n = 5) which had injection cannulae implanted were anesthetized with isoflurane (4%
in O2 at 1 liter per minute). A 26 ga bilateral guide cannula assembly (Plastics One,
Roanoke, VA) was implanted 2mm above the VP (the injection cannula extended 2 mm past
the guide cannula to the target region). Stereotaxic coordinates relative to bregma for the
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guide cannula were: AP −.26mm; LM +/− 2.5mm; DV −6.0mm (Paxinos and Watson,
1986). The guide cannula assembly was secured to the skull with small stainless steel screws
and dental cement. Dummy cannula extending 0.5 mm beyond the guide cannula tips were
inserted and a dust cap was attached to the top of the cannula assembly. After surgery, the
rats were given meloxicam (1 mg/kg, s.c.) once to minimize pain and discomfort and
allowed to recover for at least 7 days before experiments.
Stainless steel injection cannula (33 ga) cut to extend 2 mm beyond the guide cannula was
used for infusions. PE-10 tubing was used to connect the injection cannula to 25µl syringes
(Hamilton; Reno, NV) which were attached to infusion pumps (Harvard Apparatus;
Cambridge, MA). For the infusions, the rats were confined to a small polyethylene box.
Each infusion was given in a volume of 0.5 µl/side over 30 s. The injector cannula was left
in place for an additional 30 s after the infusion, then the injector cannula was removed, and
the dummy cannula and dust cap were reinserted. For the rats that received both CART
peptide (Peptides International Inc., Louisville, KY) and cocaine (NIDA; National Institute
of Health, Bethesda, MD), the i.p. cocaine injection was given 1 min after the CART
infusion.
Locomotor activity was measured in photocell cages (Omnitech Electronics; Columbus,
OH) measuring 40 × 40 × 30 cm. Each cage had 32 photocells (16 front to back and 16 side
to side) positioned 5 cm off the cage floor. Each cage was isolated in a stainless steel box
equipped with a ventilated fan, 10W light bulb and a keyhole to observe the rats. The
distance traveled (in cm) was calculated by measuring the consecutive breaks of adjacent
photocell beams. Operation of the photocell cages and data collection was done by an IBM
computer.
For the infusions, each rat was put into the photocell cage for 1 h for habituation, given the
infusion, then returned to the cages for an additional hour. Prior to the start of the
experiments, each rat was habituated to the testing procedure and environment by receiving
daily sham injections for 3 days.
Results
Anterograde projections of CART neurons from the NAcc to the VP
Eight rats were injected intra-accumbally and unilaterally with PHA-L as described in
Methods. A typical distribution of the PHA-L in brain is shown in Figure 1. The
immunohistochemical localization of both PHA-L and CART peptides were determined in
the NAcc and VP, and an example of the results is shown in Figure 2. Fluorescence
immunocytochemistry for CART peptide alone (green) demonstrated a dense locus of
immunoreactivity in the neuropil of the subcommissural VP (Figure 2D) and in the NAcc
(Figure 2A), and the latter is well established. It was of interest that no cell bodies staining
for CART were found in the VP. Also, PHA-L (red) was found in the VP (Figure 2E), and
colocalization studies revealed that there was a significant colocalization of both PHA-L and
CART in the VP (yellow stain, Figure 2F). Also, both CART and PHA-L were found in the
NAcc (Figure 2B and C), particularly near the injection site, as expected. The colocalization
of CART and PHA-L in the VP indicates that CART peptide-containing neurons project to
the VP.
A retrograde tracer injected into the subcommissural VP labeled CART-containing cell
bodies in the NAcc
Injection of R-DA into the VP (n=8) ventral to the decussation of the anterior commissure
resulted in the labeling of cell bodies in the NAcc and examples of the results are shown in
Figure 3. The injections evaluated in this study were localized using immunofluorescence in
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the VP immediately ventral to the anterior commissure according to the atlas of Paxinos and
Watson (Paxinos and Watson, 1986) (Figure 3). The injection sites in the VP displayed
strong CART immunoreactivity, in addition to a very strong presence of the fluorescent
tracer, as expected, and they colocalized near the injection site, also as expected (Figure 3A,
B, C). In the NAcc (Figure 3D, E, F,), cell bodies were clearly labeled by R-DA (Figure 3E).
Many of these cell bodies colocalized (Figure 3F) both CART peptides and R-DA,
confirming that CART is present in the NAcc to VP projection.
Electron microscopic analysis of CART-immunoreactive nerve terminals reveals
symmetric synapses onto VP dendrites
CART immunoreactivity was examined in the VP (n=4 animals) at the electron microscopic
level as described in Methods. The majority of elements labeled were axon terminals (n=161
total immunopositive terminals examined), with additional labeling observed in preterminal
axons (Figure 4). No cell bodies or dendrites were immunoreactive for CART, confirming
the light microscopic observations. For 62 of the CART peptide–positive nerve terminals,
the synaptic junctions were either not visible or not easily identifiable. In the remaining 99
nerve terminals, CART peptide immunoreactivity was only present in presynaptic elements
and nerve terminals making symmetric synapses on dendritic elements, even though
unstained, asymmetric junctions were observed in the same fields. The terminals that
displayed CART immunoreactivity were small and densely packed with synaptic vesicles
(Figure 4A, B). Since our anterograde tracing experiments suggest that these CART
projections are from the NAcc, it is reasonable to assume that the morphology of the
terminals is similar to that of NAcc terminals that synapse in other nuclei. Terminals of
NAcc neurons in the SN do indeed have similar morphology to the CART-immunoreactive
terminals in the VP (Hubert et al., 2001).
Intra-VP injection of CART peptide inhibits cocaine-stimulated locomotor activity but has
no effect on basal locomotor activity
The location and distribution of CART peptide after injection into the VP was first
simulated by injecting BDA, a marker that is relatively easy to visualize, through the
cannulae in a manner identical to that of the CART injections. The BDA was then visualized
by a chromogenic reaction. As expected, the injection site was in the subcommissural VP
(Figure 5).
In behavioral studies, injection of CART peptide into the VP had no effect on basal
locomotor activity at all time points tested and at both doses (Figure 6). However, at 10 and
20 minutes post-cocaine injection, there was a significant effect of CART peptide on
locomotor activity of rats with respect to treatment (F(2,36)=9.536, p<0.05). Post-hoc
comparisons using Tukey’s test indicate a significant decrease in locomotor activity in the
group receiving 2.5 µg of CART in the VP at the 10- and 20-minute time points. These
results parallel those found for intra-accumbal administrations of CART on cocaine- or
amphetamine-induced locomotor activity (Jaworski et al., 2003a, Jaworski et al., 2003b,
Kim et al., 2003).
Discussion
The VP was first noticed as a nucleus that received a significant projection from the nucleus
accumbens (Heimer, 2003). Due to the fact that it, as well as the NAcc, receives projections
from both the basal ganglia proper and nuclei that are now recognized as part of the
extended amygdala system, it has been postulated that the VP is a site for limbic-motor
integration (Mogenson and Yang, 1991). Our results demonstrate that CART peptide is
Hubert et al. Page 6













present in the NAcc to VP projection and likely plays a role in the motor functionality of the
VP.
The high level of CART immunoreactivity in the VP demonstrated in this study is supported
by a previous immunocytochemical study that examined CART immunoreactivity
throughout the rat brain (Koylu et al., 1998). No CART immunoreactive cell bodies were
observed in the VP, but a dense innervation of neuronal processes was present. An
anterograde tracer injected into the NAcc produced labeled neuronal axons and terminals in
the VP. These processes were often colocalized with CART peptide immunoreactivity
suggesting that CART peptide-containing neurons in the NAcc projected to the VP. These
findings were confirmed by additional studies where a retrograde tracer injected into the VP
labeled CART-immunoreactive cell bodies in the NAcc. The NAcc to VP projection is
known to contain GABA and a number of neuropeptides. The discovery of CART peptide
and its localization with substance P and dynorphin in GABAergic accumbal efferents
suggest a role for CART in neuronal functions in nuclei that receive projections from the
NAcc, including the VP. These results indicate a CART pathway between the NAcc and the
VP.
The VP has long been considered part of the basal ganglia in a loop that includes the NAcc.
This circuit was proposed to subserve locomotor activity in the context of repetitive and
reinforced behavior (Kretschmer, 2000). Formerly, the VP was considered to be simply a
relay nucleus for processing this information, but increased anatomical and behavioral
studies have demonstrated that the VP integrates information from several limbic sources
including the NAcc (Fuller et al., 1987, Klitenick et al., 1992). Injection of a number of
drugs, including µ-opiate, δ-opiate, dopaminergic and glutamatergic agonists, into the VP
can induce spontaneous locomotor activity (Shreve and Uretsky, 1989, Austin and Kalivas,
1990, Klitenick et al., 1992, Napier and Chrobak, 1992, Hooks and Kalivas, 1994, Gong et
al., 1997). Intrapallidal injections of the GABA-A agonist, muscimol, can attenuate
locomotor activity induced by pharmacological stimulation of the NAcc (Austin and
Kalivas, 1989). Also, injection of a D1 agonist, but not a D2 agonist, into the VP increases
locomotor activity (Gong et al., 1999). This is interesting in that it suggests that dopamine
receptors in the VP, in addition to the more well-known NAcc dopaminergic system, can be
involved in locomotor behavior. Since locomotor activity can be modulated by manipulation
of a variety of neurotransmitter systems in the VP, it is not surprising that CART injected
into the VP can reduce psychomotor stimulant-induced locomotor activity as shown in this
study. Thus, the actions of CART in the VP seem to attenuate dopaminergic function, as is
also observed in the NAcc (Jaworski et al., 2003a, Kim et al., 2003, Jaworski et al., 2007,
Hubert et al., 2008, Jaworski et al., 2008, Rogge et al., 2008) and the VTA (Jaworski et al.,
2008).
Studies on the NAcc and its dopaminergic innervation have often found that agents that
produce locomotor activity are generally reinforcing (Mogenson et al., 1980). This seems to
hold true in the VP as well. Intracranial self-stimulation (ICSS) is supported throughout the
VP in rats (Panagis et al., 1995). Psychomotor stimulants such as cocaine decrease the
current threshold for ICSS in the VP (Panagis and Spyraki, 1996). Dopamine antagonists
increase the threshold for ICSS, though this might be a secondary effect of general motoric
inhibition. Intra-VP administration of amphetamine and cocaine also induce a conditioned
place preference (CPP), which supports a role for pallidal DA in reward-related processes
(Gong et al., 1996). Interestingly, injections of substance P, which is colocalized with CART
in NAcc efferents, into the VP also produce CPP (Nikolaus et al., 1999). If both substance P
and CART are released from accumbal terminals in the VP as suggested by our anatomical
findings, it will be interesting to examine if they are mutually inhibitory, and under what
conditions each transmitter is released. It is also important to discover if CART peptide
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injections into the VP can attenuate the local effects of dopamine relative to reward and
reinforcement, as is seen in the NAcc (Jaworski et al., 2003a, Jaworski et al., 2008).
Recent research has examined the balance between the neural substrates of incentive and
reward, i.e., between “wanting” and “liking”, in the VP (Smith and Berridge, 2005, Smith et
al., 2009). Opioids and GABA, both contained in NAcc efferents to the VP, are both
involved in the wanting of food reward, but only opiates affected the reward value of
sucrose. Smith and Berridge (Smith and Berridge, 2005) mapped regions of the VP to
determine the key area that enhances reward and incentive properties of food and sucrose
and demonstrated that the posterior VP is a “hotspot” for opiate modulation of these
processes. CART peptide also has been shown to modulate feeding behavior, although all of
the sites mediating this are unknown (Rogge et al., 2008). However, given that lesions of the
VP can produce adipsia and aphagia, and that CART significantly innervates the VP as
shown here, it is possible that CART actions in the VP can affect feeding behavior by
modulation of “wanting” and/or “liking” circuits. The modulation of “wanting” circuits may
also be predicted by the ability of CART to modulate locomotion induced by manipulation
of dopaminergic systems.
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Abbreviations
CART Cocaine and Amphetamine-Regulated Transcript
NAcc Nucleus Accumbens
VP Ventral Pallidum
SNr Substantia Nigra pars Reticulata
PB Phosphate Buffer
PBS Phosphate-Buffered Saline
PHA-L Phaseolus Vulgaris Leucoagglutinin
r-DA Rhodamine-conjugated Dextran Amines
FITC Fluorescein Isothiocyanate
BSA Bovine Serum Albumin
NDS Normal Donkey Serum
NGS Normal Goat Serum
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Anterograde studies and site of injection and distribution of PHA-L in the rat nucleus
accumbens (NAcc). The upper left portion of the figure shows an injection site
immunoreactive for PHA-L . The three schematics shown are from one representative rat
and demonstrate the extent of the spread of the stain, at three different anatomical levels
according to Paxinos and Watson (1986).
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Fluorescence immunocytochemistry of CART peptides and PHA-L in the NAc (A–C) and
VP (D–F) in anterograde studies. CART peptide is shown in green and PHA-L in red.
Colocalization sites are stained yellow and arrows indicate some of the colocalization sites
for CART and PHA-L. See text for details. Scale Bars: 20µm
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Fluorescence immunocytochemistry for CART peptides and Rhodamine-conjugated dextran
amines (R-DA) in the VP (A–C) and in the Nucleus Accumbens (D–F) in the retrograde
transport studies. CART peptide immunoreactivity is shown in green and rhodamine is red.
Colocalization is identified by the yellow colored elements. See text for details and
interpretation.
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EM immunoperoxidase immunocytochemistry for CART in the VP. The CART antibody
labeled presynaptic elements exclusively. A and B are photos from two different animals
with basically the same information. The morphology of these CART-staining nerve
terminals is similar to that of accumbal-derived terminals found in the substantia nigra,
which suggests they are terminals of the same type of neuron. Scale Bar = 500nm. See text
for discussion.
Hubert et al. Page 15














Confirmation of the site of injection of and the distribution of CART peptide in the VP in a
typical animal. BDA, which was easy to visualize, was injected through indwelling cannulae
in a manner identical to that of CART injections as described in the text. Coordinates of
coronal sections are according to Paxinos and Watson (1986). See text for additional details.
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Locomotor activity of rats following injections of Intra-VP CART alone and Intra-VP
CART plus i.p. cocaine (10mg/kg). Injection of CART peptide into the VP had no effect on
basal locomotor activity (left side) at all times points tested and at all doses infused (Figure
6). However, at 10 and 20 minutes post-cocaine injection (right side), there was a significant
effect on locomotor activity of rats with respect to treatment (F(2,36)=9.536, p<0.05; Figure
6). Post-hoc comparisons using Tukey’s test indicate a significant decrease in locomotor
activity in the group receiving 2.5 µg of CART in the VP at the 10- and 20-minute time
points (asterisks).
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